FIELD: oncological diseases.
SUBSTANCE: invention is designed for use in complex treatment of urinary bladder cancer in case of propagation of tumor to sub-epithelium connective tissue. Method comprises transurethral resection and introduction of immune preparations and furacillin solution. Once transurethral resection completed, three-way Foli catheter is transurethrally introduced to patient, through which mixture of standard furacillin solution with 10·106 ME interferon α-2β is injected from the first postoperative day and over following 3-5 postoperative days bringing summary dose of interferon to 50·106 ME.
EFFECT: prevented traumatism of urinary bladder due to single introduction of catheter and assured continuous action of drugs without development of immune complications.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ORGANISM DISINTOXICATION IN SURGERY OF INVASIVE CANCER OF URINARY BLADDER | 2006 |
|
RU2370263C2 |
METHOD OF PREVENTING RECURRENCE OF SUPERFICIAL URINARY BLADDER CANCER | 2007 |
|
RU2354386C1 |
METHOD FOR ENDOSCOPIC TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER | 2014 |
|
RU2556612C1 |
METHOD OF COMPLEX TREATMENT AND PREVENTION OF RECURRENCES OF MUSCULAR-NON-INVASIVE FORMS OF URINARY BLADDER CANCER | 2013 |
|
RU2560314C2 |
METHOD OF TREATMENT OF SUPERFICIAL CANCER OF BLADDER | 2007 |
|
RU2350338C2 |
METHOD OF CHEMOTHERAPY AT BLADDER CANCER | 2007 |
|
RU2352340C1 |
METHOD OF DETERMINING THE VIABILITY OF OVUM AND EMBRIO MAMMALIA | 0 |
|
SU1066553A1 |
METHOD OF POSTOPERATIVE THERAPY OF NON-MUSCLE INVASIVE BLADDER CANCER | 2009 |
|
RU2443423C2 |
METHOD FOR PERCUTANEOUS ENDOSCOPIC PELVIC TUMOR REMOVAL BY A SINGLE UNIT | 2019 |
|
RU2718307C2 |
METHOD FOR TREATING MALIGNANT NEOPLASMS | 2017 |
|
RU2654701C1 |
Authors
Dates
2005-08-10—Published
2004-01-13—Filed